Remedeine Forte tablets

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активний інгредієнт:

Dihydrocodeine tartrate; Paracetamol

Доступна з:

Crescent Pharma Ltd

Код атс:

N02AJ01

ІПН (Міжнародна Ім'я):

Dihydrocodeine tartrate; Paracetamol

Дозування:

30mg ; 500mg

Фармацевтична форма:

Oral tablet

Адміністрація маршрут:

Oral

Клас:

Schedule 5 (CD Inv)

Тип рецепту:

Valid as a prescribable product

Огляд продуктів:

BNF: 04070100; GTIN: 5012854023826

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
REMEDEINE FORTE tablets
Co-Dydramol 30/500mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Tablet containing paracetamol 500 mg and dihydrocodeine tartrate BP 30
mg
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet
White to off-white, circular, flat faced tablet with a bevelled edge.
The tablet is
engraved
PD
30
on one side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the treatment of severe pain where there is a higher analgesic
requirement (higher
than tablets of 500/20 mg).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults _
1 or 2 tablets every four to six hours when necessary to a maximum of
8 tablets in 24
hours.
_Elderly _
One tablet every 4 - 6 hours increasing to two tablets every 4 - 6
hours if required and
tolerated. Do not exceed eight tablets in any 24 - hour period.
_Paediatric population_
_Children 16 to 18 years _
1 or 2 tablets every six hours when necessary to a maximum of 8
tablets in 24 hours.
_Children 12 to 15 years _
1 tablet every six hours when necessary to a maximum of 4 tablets in
24 hours.
_Children under 12 years _
Not recommended.
Method of administration
For oral use.
This medicine should, if possible, be taken during or after meals.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients
listed in section
6.1.
Respiratory depression.
Obstructive airways disease.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
This medicine should be given with caution in patients with allergic
disorders and
should not be given during an attack of asthma. Caution should also be
observed if
there is marked impairment of liver function, advanced kidney disease
and in chronic
alcoholics.
_Risk from concomitant use of sedative medicines such as
benzodiazepines or related _
_drugs: _
Concomitant use of this medicine and sedative medicines such as
benzodiazepines or
related drugs may result in sedation, respiratory depression, coma and
death. Because
of